Humanigen, Inc. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported revenue was USD 1.04 million. Net loss was USD 66.74 million compared to USD 30.75 million a year ago. Basic loss per share from continuing operations was USD 1.12 compared to USD 0.71 a year ago. For the nine months, revenue was USD 2.56 million. Net loss was USD 203.11 million compared to USD 57.24 million a year ago. Basic loss per share from continuing operations was USD 3.56 compared to USD 1.79 a year ago.